Subramaniyan Bharathiraja

Dr. Subramaniyan Bharathiraja


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2017 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SMSudip Mondal
Sudip Mondal
MPManivasagan Panchanathan
Manivasagan Panchanathan
SBSubramaniyan Bharathiraja
Subramaniyan Bharathiraja
SMSANTHAMOORTHY MADHAPPAN
SANTHAMOORTHY MADHAPPAN
VNVan Tu Nguyen
Van Tu Nguyen
JOJunghwan Oh
Junghwan Oh
Targeting cancer cells without injuring normal cells is the prime objective in treatment of cancer. In this present study, solvothermal and wet chemical precipitation techniques were employed to synthesize iron oxide (IO), hydroxyapatite (HAp), and hydroxyapatite coated iron oxide (IO-HAp) nanoparticles for magnetic hyperthermia mediated cancer therapy. The synthesized well dispersed spherical IO-HAp nanoparticles, magnetite, and apatite phases were confirmed by X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR) and Field emission transmission electron microscopy (FETEM) with Energy Dispersive X-ray spectroscopy (EDS). The non-toxic behavior of synthesized IO-HAp nanoparticles was confirmed by cytotoxicity assay (Trypan blue and MTT assay). The synthesized nanoparticles revealed a remarkable magnetic saturation of 83.2 emu/g for IO and 40.6 emu/g for IO-HAp nanoparticles in presence of 15,000 Oe (1.5 T) magnetic field at room temperature (300 K). The magnetic hyperthermia study that was performed with IO-HAp nanoparticles showed an excellent hyperthermia effect (SAR value 85 W/g) over MG-63 osteosarcoma cells. The in vitro hyperthermia temperature (~45 °C) was reached within 3 min, which shows a very high efficiency and kills nearly all of the experimental MG-63 osteosarcoma cells within 30 min exposure. These results could potentially open new perceptions for biomaterials that are aimed for anti-cancer therapies based on magnetic hyperthermia.

3 November 2016 in Molecules
Verified
Journal Article
Open access
PDF file
SBSubramaniyan Bharathiraja
Subramaniyan Bharathiraja
SHSeo Hansu
Seo Hansu
MPManivasagan Panchanathan
Manivasagan Panchanathan
SMSANTHAMOORTHY MADHAPPAN
SANTHAMOORTHY MADHAPPAN
SPSuhyun Park
Suhyun Park
JOJunghwan Oh
Junghwan Oh
C-phycocyanin, a natural blue-colored pigment-protein complex was explored as a novel photosensitizer for use in low-level laser therapy under 625-nm laser illumination. C-phycocyanin produced singlet oxygen radicals and the level of reactive oxygen species (ROS) were raised in extended time of treatment. It did not exhibit any visible toxic effect in the absence of light. Under 625-nm laser irradiation, c-phycocyanin generated cytotoxic stress through ROS induction, which killed MDA-MB-231 breast cancer cells depending on concentrations. Different fluorescent staining of laser-treated cells explored apoptotic cell death characteristics like the shrinking of cells, cytoplasmic condensation, nuclei cleavage, and the formation of apoptotic bodies. In conclusion, phycocyanin is a non-toxic fluorescent pigment that can be used in low-level light therapy.

1 October 2016 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SSSivasankara Narayani Somasundaram
Sivasankara Narayani Somasundaram
SSSaravanan Shanmugam
Saravanan Shanmugam
SBSubramaniyan Bharathiraja
Subramaniyan Bharathiraja
RJRavindran Jaganathan
Ravindran Jaganathan

26 February 2018 in Polymers
Verified
Journal Article
Open access
PDF file
MPManivasagan Panchanathan
Manivasagan Panchanathan
SBSubramaniyan Bharathiraja
Subramaniyan Bharathiraja
SMSANTHAMOORTHY MADHAPPAN
SANTHAMOORTHY MADHAPPAN
SMSudip Mondal
Sudip Mondal
NPNguyen Thanh Phuoc
Nguyen Thanh Phuoc
JOJunghwan Oh
Junghwan Oh
Photothermal therapy (PTT) using biocompatible nanomaterials have recently attracted much attention as a novel candidate technique for cancer therapy. In this work we report the performance of newly synthesized multidentate chitosan oligosaccharide modified gold nanorods (AuNRs-LA-COS) as novel agents for PTT of cancer cells due to their excellent biocompatibility, photothermal stability, and high absorption in the near-infrared (NIR) region. The AuNRs-LA-COS exhibit a strong NIR absorption peak at 838 nm with a mean length of 26 ± 3.1 nm and diameter of 6.8 ± 1.7 nm, respectively. The temperature of AuNRs-LA-COS rapidly reached 52.6 °C for 5 min of NIR laser irradiation at 2 W/cm2. The AuNRs-LA-COS had very low cytotoxicity and exhibited high efficiency for the ablation of breast cancer cells in vitro. The tumor-bearing mice were completely ablated without tumor recurrence after photothermal treatment with AuNRs-LA-COS (25 µg/mL) under laser irradiation. In summary, this study demonstrated that AuNRs-LA-COS with laser irradiation as novel agents pave an alternative way for breast cancer therapy and hold great promise for clinical trials in the near future.

20 April 2016 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SBSubramaniyan Bharathiraja
Subramaniyan Bharathiraja
MPManivasagan Panchanathan
Manivasagan Panchanathan
NBNhat Quang Bui
Nhat Quang Bui
YOYun-Ok Oh
Yun-Ok Oh
ILIn Gweon Lim
In Gweon Lim
JOJunghwan Oh
Junghwan Oh
Astaxanthin, a kind of photosynthetic pigment, was employed for gold nanoparticle formation. Nanoparticles were characterized using Ulteraviolet-Visible (UV-Vis) spectroscopy, transmission electron microscopy, and X-ray diffraction, and the possible presence of astaxanthin functional groups were analyzed by Fourier transform infrared spectroscopy (FTIR). The cytotoxic effect of synthesized nanoparticles was evaluated against MDA-MB-231 (human breast cancer cells) using a tetrazolium-based assay, and synthesized nanoparticles exhibited dose-dependent toxicity. The morphology upon cell death was differentiated through fluorescent microscopy using different stains that predicted apoptosis. The synthesized nanoparticles were applied in ultrasound-coupled photoacoustic imaging to obtain good images of treated cells. Astaxanthin-reduced gold nanoparticle has the potential to act as a promising agent in the field of photo-based diagnosis and therapy.